Health care to HIV/AIDS patients in Brazil;Assistência aos pacientes com HIV/Aids no Brasil

Revista de Saude Publica

Volumn 40, Issue SUPPL., 2006, Pages 70-79

  Portela, Margareth Crisóstomo ^a   Lotrowska, Michel ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Médicos Sem Fronteiras   (Brazil)

Author keywords

Acquired immunodeficiency syndrome, prevention control; Acquired immunodeficiency syndrome, therapy; AIDS related opportunistic infections, prevention control; AIDS related opportunistic infections, therapy; Anti HIV agents, economics; Anti HIV agents, supply distribution; Delivery of heath care, organization administration; Health services administration; HIV long term survivors; SUS (BR)

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; EPIDEMIC; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PATIENT RIGHT; PHARMACEUTICAL CARE; SUSTAINABLE DEVELOPMENT; VACCINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; BRAZIL; DELIVERY OF HEALTH CARE; HIV INFECTIONS; HUMANS; NATIONAL HEALTH PROGRAMS; NEEDS ASSESSMENT; PATIENT ADMISSION;

EID: 33744477621     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102006000700010     Document Type: Article

References (13)

1. Barth-Jones DC, Cheng H, Kang LY, Kenya PR, Odera D, Mosqueira NR et al. Cost effectiveness and delivery study for future HIV vaccines. AIDS. 2005;19:W1-W6.
2. Berkman A, Garcia J, Munõz-Laboy M, Paiva V, Parker R. A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries. Am J Public Health. 2005;95:1162-72.
3. a ed. São Paulo: Saraiva; 2005. p. 757.
4. a ed. São Paulo: Saraiva; 2005. p. 757.
5. Brasil. Lei no 8.666, de 21 de junho de 1993. Regulamenta o artigo 37, inciso XXI da onstituição Federal, institui normas para licitações e contratos da Administração Pública e dá outras providências. Constituição Federal, Coletânea de legislação administrativa. In: O Medauar, organizador. São Paulo: Revista dos Tribunais; 2002. p. 579.
6. Galvão J. Access to antiretroviral drugs in Brazil. Lancet. 2002;360:1862-5.
7. Galvão J. Brazil and acess to HIV/AIDS drugs: a question of human rights and Public Health. Am J Public Health. 2005;95:1110-6.
8. Marins JRP, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675-82.
9. Melchior R, Nemes MIB, Basso CR, Castanheira ERL, Alves MTSB, Buchalla CM et al. Evaluation of the organizational structure of HIV/AIDS outpatient care in Brazil. Rev Saúde Pública. 2006;40:1-9.
10. Nemes MIB, Castanheira ERL, Melchior R, Alves MTSB, Basso CR. Avaliação da qualidade da assistência no programa de Aids: questões para a investigação em serviços de saúde no Brasil. Cad Saúde Pública. 2004; 20:S310-S21.
11. Organização Mundial de Saúde - OMS. In: Centro Colaborador da OMS para a Classificação de Doenças em Português, tradução. Classificação estatística internacional de doenças e problemas relacionados à saúde, décima revisão (CID-10). São Paulo: Editora da Universidade de São Paulo; 1999.
12. Saraceni V, Cruz MM, Lauria LM, Durovni B. Trends and characteristics of AIDS mortality in the Rio de Janeiro City after the introduction of highly active antiretroviral therapy. BJID. 2005;9:209-15.
13. United Nations. General Assembly. Declaration of commitment on HIV/AIDS. Disponível em http://www.un.org/ga/aids/docs/aress262.pdf [acesso em 1 mar 2006]